Learn more about our Diagnostics work.
Washington, D.C.— AdvaMedDx® has submitted comments on draft legislation, the Verifying Accurate Leading-Edge IVCT Development (VALID) Act, commending Congress for their support of comprehensive, risk-based diagnostics regulatory reform. “An overarching,…
Washington, D.C. – The U.S. Department of Health and Human Services (HHS) has appointed Dr. Christine C. Ginocchio, Ph.D, MT (ASCP) to the Presidential Advisory Council on Combatting Antibiotic Resistant…
WASHINGTON, D.C. – In partnership with the Centers for Disease Control and Prevention (CDC) through the Antimicrobial Resistance (AMR) Challenge, AdvaMedDx® and several AdvaMedDx® member companies made public commitments to…
Washington, D.C. – AdvaMedDx® applauds Capitol Hill’s release of technical assistance (TA) developed by the Food and Drug Administration (FDA) to draft legislation authored by Representatives Larry Bucshon (R-IN) and…
More than 80 Groups Unite for the First Time to Call for Legislative Reform Washington, D.C. – Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called…
WASHINGTON, D.C. – AdvaMedDx®, a division of the Advanced Medical Technology Association® (AdvaMed®) that focuses on the value diagnostics bring to patients’ health and health care, while addressing the need for regulatory…
GENEVA, SWITZERLAND – On January 18, the AMR Industry Alliance launched its first report that shows the commitment of the life sciences industry to tackle the public health threat of…